Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-24-000222
Filing Date
2024-02-14
Accepted
2024-02-14 18:48:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 tffpharm13ga2.htm SC 13G/A 29595
  Complete submission text file 0000935836-24-000222.txt   30889
Mailing Address 467 CENTRAL PARK WEST NY NY 10025
Business Address
LYTTON LAURENCE W (Filed by) CIK: 0001105806 (see all company filings)

Type: SC 13G/A

Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Subject) CIK: 0001733413 (see all company filings)

EIN.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91311 | Film No.: 24641343
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)